This result along with the missing correlation between concentrations of anti-dsDNA and complement C3 for the ELiA dsDNA test (when SLE and control patients were considered together) might be attributed to the limited amount of SLE patients with severe disease activity within the investigated patient cohort. The gene discussed is C3; the disease is systemic lupus erythematosus.